NCT03585153Enrolling by invitation
Multicenter Assessment of the Pancreas in Type 1 Diabetes
Source: ClinicalTrials.gov · Last updated 23 Oct 2026
Brief summary (registry, in English)
The overall goal of this research is to develop and validate standard operating procedures (SOP) to assess the human pancreas in individuals with type 1 diabetes (T1D) and other forms of diabetes using advanced, quantitative magnetic resonance imaging (MRI) approaches.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 18 Jun 2018
- Start date
- 19 Feb 2014
- Primary completion date
- Dec 2028
- Lead sponsor
- Vanderbilt University Medical Center
- Diseases
- Type 1 diabetes
- NCT number
- NCT03585153
What you commit to
- Study type: Observational
- Planned participants: 250
- From 19 Feb 2014 to the primary completion date, Dec 2028
- 5 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Subjects with pancreatitis, cystic fibrosis, pancreatic adenocarcinoma, or neuroendocrine tumors
- Subjects who have any type of bioimplant activated by mechanical, electronic, or magnetic means because such devices may be displaced or malfunction
- Subjects who have any type of ferromagnetic bioimplant that could potentially be displaced
- Subjects who are pregnant or breast-feeding. Urine pregnancy test will be performed on women of child bearing potential who are not practicing appropriate contraception measures or menstruating.
- Subjects who exhibit significant anxiety and/or claustrophobia
- Subjects incapable of giving assent/informed written consent
- For controls: subjects who have first degree relatives with T1D
Who the study is looking for
- Subjects at least 8 years of age
- Subjects with T1D must be imaged within 100 days of their date of diagnosis
- Subjects must be able to read and provide assent/informed written consent
Age in the registry: 8 years to - · Sex: All · Accepts healthy volunteers
Sites (5)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| St. Vincent's Institute of Medical Research Coordinator of this site? Confirm its status | Melbourne | Australia | Unknown status |
| University of Colorado, Barbara Davis Center Coordinator of this site? Confirm its status | Aurora | United States | Unknown status |
| University of Texas at Austin, Dell Medical School Coordinator of this site? Confirm its status | Austin | United States | Unknown status |
| University of Chicago, Kovler Diabetes Center Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
| Vanderbilt University Medical Center Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.